<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CEP</journal-id>
<journal-id journal-id-type="hwp">spcep</journal-id>
<journal-title>Cephalalgia</journal-title>
<issn pub-type="ppub">0333-1024</issn>
<issn pub-type="epub">1468-2982</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0333102412458187</article-id>
<article-id pub-id-type="publisher-id">10.1177_0333102412458187</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A very high prevalence of migraine in adult general population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Panconesi</surname><given-names>Alessandro</given-names></name>
<xref ref-type="corresp" rid="corresp1-0333102412458187"/>
</contrib>
</contrib-group>
<aff id="aff1-0333102412458187">Headache Centre, Department of Neurology, San Giuseppe Hospital, Empoli, Italy</aff>
<author-notes>
<corresp id="corresp1-0333102412458187">Alessandro Panconesi, Headache Centre, Department of Neurology, San Giuseppe Hospital, Empoli 50053, Italy. Email: <email>a.panconesi@virgilio.it</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>32</volume>
<issue>14</issue>
<fpage>1084</fpage>
<lpage>1085</lpage>
<permissions>
<copyright-statement>© International Headache Society 2012 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">International Headache Society</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Dear Sir,</p>
<p>I read with great surprise the article of Ferrante et al. (<xref ref-type="bibr" rid="bibr1-0333102412458187">1</xref>), published in <italic>Cephalalgia</italic>, concerning an observational study in collaboration with general practitioners (GPs) about the prevalence of migraine in the Italian city of Parma. They reported a very high prevalence compared to many previous epidemiological studies performed worldwide. They found a prevalence of 24.7% of definite migraine (DM) and 5.1% of probable migraine (PM): so migraine sufferers are about one third of the population. A previous multicentre study conducted by GPs in Italy found a prevalence of 6.9% of DM and 4.6% of PM (<xref ref-type="bibr" rid="bibr2-0333102412458187">2</xref>). The authors discussed that the differences between their results and literature data are likely to be due to different methodological approaches.</p>
<p>The reported high prevalence contrasts with two aspects of migraine management not only at primary care level in Italy, but also worldwide:
<list id="list1-0333102412458187" list-type="order">
<list-item><p>The migraine diagnosis registered in the GP’s databases in Italy is rather low. The analysis of about 600,000 patient records, carefully conducted with ‘Health Search’ (a method dedicated to optimize the registration of every problem in the electronic records), shows a percentage of 1.39% of migraine in 2001 and of 4.4% of headache not otherwise specified (<xref ref-type="bibr" rid="bibr3-0333102412458187">3</xref>). The same analysis repeated in 2006 reported a percentage of migraine diagnosis slightly higher (1.82%) (<xref ref-type="bibr" rid="bibr4-0333102412458187">4</xref>). These data were recently confirmed with the database analysis of a cooperative of GPs, showing 1.6% of ‘migraine’ and 2% of ‘headache’ on a population of 42,710 residents (<xref ref-type="bibr" rid="bibr5-0333102412458187">5</xref>).</p></list-item>
<list-item><p>A low percentage (about 0.5%) of triptan users in the general population was reported by some epidemiological studies (<xref ref-type="bibr" rid="bibr6-0333102412458187">6</xref>,<xref ref-type="bibr" rid="bibr7-0333102412458187">7</xref>) and recently confirmed (0.8%), including the same area of the authors (<xref ref-type="bibr" rid="bibr8-0333102412458187">8</xref>).</p></list-item>
</list></p>
<p>The enormous discrepancy between both the low percentage of recorded migraine diagnosis and of triptan prescription at primary care level with the high prevalence of migraine detected in epidemiological studies (in particular in that of Ferrante et al.) may be due at least in part, and for various reasons, to the under-diagnosis of migraine by GPs (<xref ref-type="bibr" rid="bibr9-0333102412458187">9</xref>).</p>
<p>However, the authors neglected to discuss and to evaluate a factor that may have been decisive in their results, namely, the method of recruitment of study participants. The study participants were recruited by GPs in 2007–2009 from those interested in participating and they arranged an interview at their office, Headache Centre or by phone. This may be the most important factor in determining the outcomes. In fact the sample covered only a proportion of patients, most likely those reaching the office of the GP for examination in the period of study, which are typically those with more diseases, including those migraine patients with more frequent and/or severe attacks and comorbidities. In addition, the GP could more easily be inclined to recruit patients already diagnosed as migraine patients in the database. Instead, the previous Italian epidemiological study covered all patients who visited the GP’s practice, for any reason, on 5 consecutive days (<xref ref-type="bibr" rid="bibr2-0333102412458187">2</xref>). Patient selection should be random or involve the entire database of a few GPs.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0333102412458187"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrante</surname><given-names>T</given-names></name><name><surname>Castellini</surname><given-names>P</given-names></name><name><surname>Abrignani</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>The PACE study: past-year prevalence of migraine in Parma’s adult general population</article-title>. <source>Cephalalgia</source> <year>2012</year>; <volume>32</volume>: <fpage>358</fpage>–<lpage>365</lpage>.</citation></ref>
<ref id="bibr2-0333102412458187"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roncolato</surname><given-names>M</given-names></name><name><surname>Fabbri</surname><given-names>L</given-names></name><name><surname>Recchia</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPs</article-title>. <source>Eur Neurol</source> <year>2000</year>; <volume>43</volume>: <fpage>102</fpage>–<lpage>106</lpage>.</citation></ref>
<ref id="bibr3-0333102412458187"><label>3</label><citation citation-type="other"><comment>Del Zotti F, Sabatini A, Sessa E. Malattie classiche e sintomi comuni: l’emicrania nel database di Health Search, <ext-link ext-link-type="uri" xlink:href="http://www.simg.it/Documenti/Rivista/2002/08-10_2002/11.pdf">http://www.simg.it/Documenti/Rivista/2002/08–10_2002/11.pdf</ext-link> 2002 (accessed 9 June 2012)</comment>.</citation></ref>
<ref id="bibr4-0333102412458187"><label>4</label><citation citation-type="other"><comment>Surace MA, Fumagalli E, Mazzoleni F. Criticità nella gestione delle cefalee in Medicina Generale, <ext-link ext-link-type="uri" xlink:href="http://www.simg.it/Documenti/Rivista/2008/01_2008/2.pdf">http://www.simg.it/Documenti/Rivista/2008/01_2008/2.pdf</ext-link> (2008, accessed 9 June 2012)</comment>.</citation></ref>
<ref id="bibr5-0333102412458187"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panconesi</surname><given-names>A</given-names></name><name><surname>Pavone</surname><given-names>E</given-names></name><name><surname>Coletta</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>A picture of migraine management in Italy</article-title>. <source>J Headache Pain</source> <year>2009</year>; <volume>10</volume>(<issue>Suppl</issue>): <fpage>S32</fpage>–<lpage>S33</lpage>.</citation></ref>
<ref id="bibr6-0333102412458187"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pavone</surname><given-names>E</given-names></name><name><surname>Banfi</surname><given-names>R</given-names></name><name><surname>Vaiani</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Patterns of triptans use: a study based on the records of a community pharmaceutical department</article-title>. <source>Cephalalgia</source> <year>2007</year>; <volume>27</volume>: <fpage>1000</fpage>–<lpage>1004</lpage>.</citation></ref>
<ref id="bibr7-0333102412458187"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panconesi</surname><given-names>A</given-names></name><name><surname>Pavone</surname><given-names>E</given-names></name><name><surname>Vacca</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Triptans in the Italian population: a drug utilization study and a literature review</article-title>. <source>J Headache Pain</source> <year>2008</year>; <volume>9</volume>: <fpage>71</fpage>–<lpage>76</lpage>.</citation></ref>
<ref id="bibr8-0333102412458187"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biagi</surname><given-names>C</given-names></name><name><surname>Poluzzi</surname><given-names>E</given-names></name><name><surname>Roberto</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy</article-title>. <source>Eur J Clin Pharmacol</source> <year>2011</year>; <volume>67</volume>: <fpage>1283</fpage>–<lpage>1289</lpage>.</citation></ref>
<ref id="bibr9-0333102412458187"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panconesi</surname><given-names>A</given-names></name><name><surname>Bartolozzi</surname><given-names>ML</given-names></name><name><surname>Salvadori</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Reasons for under-diagnosis of migraine in primary care</article-title>. <source>J Headache Pain</source> <year>2011</year>; <volume>12</volume>(<issue>Suppl</issue>): <fpage>S37</fpage>–<lpage>S38</lpage>.</citation></ref>
</ref-list>
</back>
</article>